XIFAXAN ® (rifaximin) 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults and for the treatment of irritable bowel syndrome with diarrhea ...

You can access a range of bibliographical databases with your NHS OpenAthens account. Sign in to see what you can access. You can access bibliographic databases from the providers' websites. For ...

Sequencing of the genome of a newly isolated marine actinomycete has revealed the potential to make a gamut of interesting compounds with potential as therapeutic agents. Deep-sea environments may ...

We initiated an antimicrobial therapy (rifamycin 250 mg/d for two weeks) and then performed a surgical excision of the eschar. The surgical wound, treated with topical antimicrobial agents (silver ...

Rifaximin is a semi-synthetic derivative of rifampin and acts by binding to the beta-subunit of bacterial DNA-dependent RNA polymerase blocking one of the steps in transcription. This results in ...

XIFAXAN is contraindicated in patients with a hypersensitivity to rifaximin, rifamycin antimicrobial agents, or any of the components in XIFAXAN. Hypersensitivity reactions have included ...